Company Filing History:
Years Active: 2016-2018
Title: John J Engel: Innovator in Pharmaceutical Chemistry
Introduction
John J Engel is a notable inventor based in Linden, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds 2 patents that focus on innovative compounds aimed at treating pain and other disorders.
Latest Patents
Engel's latest patents include "Benzomorphan analogs and the use thereof." This invention provides compounds of Formula (I) or (II) and pharmaceutically acceptable salts and solvates thereof, which are designed for the treatment of disorders responsive to modulation of one or more opioid receptors. The compounds are particularly useful for treating pain. Another significant patent is "Quaternized amines as sodium channel blockers." This disclosure presents substituted pyridine and pyrimidine compounds of Formula (I) and their pharmaceutically acceptable salts, solvates, and prodrugs. These compounds are also aimed at treating pain by blocking sodium channels.
Career Highlights
John J Engel is currently employed at Purdue Pharma L.P., where he continues to develop innovative pharmaceutical solutions. His work has significantly impacted the field of pain management through the development of novel compounds.
Collaborations
Engel collaborates with talented coworkers, including Xiaoming Zhou and Laykea Tafesse, contributing to a dynamic research environment.
Conclusion
John J Engel's work exemplifies the intersection of innovation and pharmaceutical science, with his patents paving the way for new treatments in pain management. His contributions are vital to advancing medical therapies and improving patient outcomes.